Post PCI High Sensitivity Troponin Elevation: No Prognostic Value

Post PCI High Sensitivity Troponin Elevation

The prognostic value of high sensitivity troponin elevation after elective PCI in patients with or without elevated baseline values remains unclear.

 

The aim of this study was to measure the prognostic value of post elective procedure high sensitivity troponin and to determine whether this may be influenced by baselines TnT values.

 

The study included 5,626 patients undergoing coronary PCI with available baseline and post procedural TnT values. Primary end point 3 year mortality (estimating the risk by logarithmic increase of high sensitivity TnT value).

 

Patients were divided in four groups:

  • nonelevated baseline and post procedure high sensitivity TnT (TnT ≤0.014 μg/l; n = 742),
  • nonelevated baseline but elevated post procedure hs TnT values (pico post-procedimiento TnT >0.014 μg/l; n = 2,721),
  • elevated baseline values (TnT >0.014 μg/l) but with no post procedure elevation (n = 516),
  • elevated baseline values with even higher post procedure elevation (n = 1,647).

 

There were 265 deaths, 6 (2.3%) in patients with normal baseline and post procedural hs TnT, 54 (20.4%) in patients with normal baseline but elevated post procedural hs TnT, 50 (18.9%) in patients with elevated baseline hs TnT but no higher post procedural hs TnT, and 155 (58.5%) in patients with high sensitivity baseline and higher post procedural hs TnT (p<0.001).

 

After adjusting, elevated baseline values (HR 1.22; IC 95% 1.09 a 1.38; p < 0.001) were associated to mortality, but not the post procedure rise of hs TnT (HR 1.04; IC 95% 0.85 a 1.28; p=0.679).

 

Peak post procedural hs TnT was not associated with increased mortality in patients with normal baseline hs Tnt values (HR 0.93; IC 95% 0.69 a 1.25; p=0.653) or elevated baseline hs TnT values (HR 1.24; IC 95% 0.91 a 1.69; p=0.165).

 

Conclusion

In patients with heart disease undergoing programmed PCI, a rise in hs TnT values after procedure does not provide prognostic information beyond baseline TnT levels.

 

Editorial Comment

The definition of periprocedural MI used in clinical studies is more associated to events, as opposed to spontaneous MI.

 

Prior studies (Comparison of the Prognosis of Spontaneous and Percutaneous Coronary Intervention–Related Myocardial Infarction, Sergio Leonardi. JACC Vol. 60, No. 22, 2012) had already shown the benign evolution of periprocedural MI and the present study brings additional information in favor of this point.

 

Original Title: High-Sensitivity Troponin T and Mortality after Elective Percutaneous Coronary Intervention.

Reference: Gjin Ndrepepa et al. J Am Coll Cardiol. 2016;68(21):2259-2268.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...